Vitamin D receptor polymorphisms in secondary hyperparathyroidism after Scopinaro's biliopancreatic diversion.
BACKGROUND
Secondary hyperparathyroidism is a frequent metabolic complication of bariatric surgery. Individual differences in calcium absorption determine chronic secondary hyperparathyroidism after biliopancreatic diversion in half of the patients who have normal levels of 25-hydroxyvitamin D. We aimed to evaluate if certain vitamin D receptor polymorphisms may be responsible for the latter. Cases and controls study including 57 patients after biliopancreatic diversion with a mean serum 25-hydroxyvitamin D above 20 ng/mL, separated into those with secondary hyperparathyroidism (n = 26, cases) and those without it (n = 31, controls).


METHODS
Genotyping for restriction-length-fragment polymorphisms of the vitamin D receptor gene was carried out for FOK1, BSM1, APA1, and TAQ1, and haplotype structure was also constructed.


RESULTS
There were no differences in the allelic or genotypes distribution of the four studied polymorphisms between patients and controls (P = 0.352 and P = 0.301 for FOK1, P = 0.733 and P = 0.924 for BSM1, P = 0.974 and P = 0.992 for APA1, and P = 0.995 and P = 0.928 for TAQ1, respectively). Haplotype analysis showed no differences between patients and controls (P = 0.495 for BAT, P = 1.000 for BAt, P = 0.508 for Bat and P = 0.924 for bAT haplotypes, respectively). Furthermore, haplotypes were not associated with serum PTH levels or with the ratio between serum PTH and 25-hydroxyvitamin D levels.


CONCLUSIONS
Chronic secondary hyperparathyroidism after biliopancreatic diversion in patients with normal levels of 25-hydroxyvitamin D is not dependent on vitamin D receptor gene polymorphisms.
Balsa
Jose A
JA
Unit of Obesity Surgery and Unit of Clinical Nutrition and Dietetics, Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Iglesias
Borja
B
Peromingo
Roberto
R
Conde
Silvia
S
Vazquez
Clotilde
C
San-Millan
Jose L
JL
Botella-Carretero
Jose I
JI
D000328:Adult; D015904:Biliopancreatic Diversion / Q000009:adverse effects*; D005260:Female; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000453:epidemiology / Q000209:etiology / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D018167:Receptors, Calcitriol / Q000235:genetics*; D012307:Risk Factors; D014807:Vitamin D / Q000031:analogs & derivatives / Q000097:blood
D018167:Receptors, Calcitriol; D014807:Vitamin D; C104450:25-hydroxyvitamin D
J Bone Miner Res. 2006 Jan;21(1):151-62
16355284
Int J Obes (Lond). 2008 Dec;32 Suppl 7:S93-7
19136998
Nefrologia. 2003;23 Suppl 2:73-7
12778859
Lancet Oncol. 2009 Jul;10(7):653-62
19556163
Obes Surg. 2010 Apr;20(4):468-73
19937150
Ann Surg. 2003 Jun;237(6):751-6; discussion 757-8
12796570
N Engl J Med. 1997 Jul 10;337(2):77-82
9211676
J Bone Miner Res. 1996 Oct;11(10):1557-65
8889857
Ann Surg. 2006 May;243(5):701-4; discussion 704-5
16633006
J Clin Invest. 1988 Jan;81(1):126-32
3335630
Endocr Rev. 2001 Aug;22(4):477-501
11493580
Osteoporos Int. 1997;7(5):439-43
9425501
Invest Clin. 2008 Mar;49(1):29-38
18524329
Ann Intern Med. 1985 Oct;103(4):516-21
4037557
Am J Hum Genet. 2005 Mar;76(3):449-62
15700229
JAMA. 2003 Jan 8;289(2):187-93
12517229
J Gastrointest Surg. 2004 Jan;8(1):48-55; discussion 54-5
14746835
Am J Hum Genet. 2001 Apr;68(4):978-89
11254454
Int J Obes Relat Metab Disord. 2003 Jan;27(1):110-6
12532162
Eur J Gastroenterol Hepatol. 2003 Aug;15(8):845-9
12867792
J Bone Miner Res. 1990 Nov;5(11):1139-42
2270777
Osteoporos Int. 2005 Jul;16(7):713-6
15776217
N Engl J Med. 2007 Aug 23;357(8):741-52
17715408
N Engl J Med. 1989 Apr 13;320(15):980-91
2648151
Arch Surg. 1996 Oct;131(10):1048-52; discussion 1053
8857901
J Bone Miner Res. 2001 Feb;16(2):379-85
11204438
World J Surg. 1998 Sep;22(9):936-46
9717419
J Endocrinol Invest. 2004 Feb;27(2):158-62
15129811
Ann Intern Med. 1991 Dec 15;115(12):956-61
1952493
Nature. 1994 Jan 20;367(6460):284-7
8161378
J Clin Gastroenterol. 2006 Sep;40(8):659-68
16940875
J Bone Miner Res. 1995 Jun;10(6):978-84
7572323
Obes Surg. 2005 Mar;15(3):330-5
15826464
J Clin Endocrinol Metab. 2004 Mar;89(3):1061-5
15001587
Surgery. 2009 Aug;146(2):375-80
19628098
Obes Surg. 2003 Jun;13(3):383-8
12841898
J Endocrinol Invest. 2008 Oct;31(10):845-50
19092286
Am J Hum Genet. 2005 Nov;77(5):807-23
16252240
J Clin Endocrinol Metab. 2006 Nov;91(11):4223-31
16954156
J Am Coll Nutr. 2003 Apr;22(2):142-6
12672710
J Bone Miner Res. 1997 Jun;12(6):922-8
9169351